SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-06-015872
Filing Date
2006-03-10
Accepted
2006-03-10 17:26:41
Documents
13
Period of Report
2006-04-26
Effectiveness Date
2006-03-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a06-3229_1def14a.htm DEF 14A 672559
2 GRAPHIC g32291dci001.gif GRAPHIC 3035
3 GRAPHIC g32291dci002.jpg GRAPHIC 2340
4 GRAPHIC g32291dei001.jpg GRAPHIC 3690
5 GRAPHIC g32292bci001.jpg GRAPHIC 740
6 GRAPHIC g32292bci002.jpg GRAPHIC 727
7 GRAPHIC g32292bci003.jpg GRAPHIC 719
8 GRAPHIC g32292bci004.jpg GRAPHIC 693
9 GRAPHIC g32292bci005.jpg GRAPHIC 692
10 GRAPHIC g32292bci006.jpg GRAPHIC 670
11 GRAPHIC g32292bci007.jpg GRAPHIC 706
12 GRAPHIC g32291dqi001.jpg GRAPHIC 29488
13 GRAPHIC g32291dqi002.jpg GRAPHIC 3690
  Complete submission text file 0001104659-06-015872.txt   740868
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 06680297
SIC: 2834 Pharmaceutical Preparations